Patent & IP news for March 22, 2013

John Locke vs. Ayn Rand from hallingblog.com

This paper is exploratory not definitive.  Comments and input is greatly appreciated.  My interest in the comparison between Rand and Locke started when I wrote my book The Decline and Fall of the American Entrepreneur ...

Share via E–mail | Twitter | Facebook

Obama Administration Solicits Public Help in Preventing Foreign Trade Secret Theft from www.patentdocs.org

By Josh Rich -- On Tuesday, the U.S. Intellectual Property Enforcement Coordinator, Victoria Espinel, published a notice in the Federal Register "requesting any recommendations for legislative changes that would enhance enforcement against, or reduce the ...

Share via E–mail | Twitter | Facebook

Competency Standards and Ethical Regulations for U.S. Intellectual Property Brokers and Other Middlemen from www.ipwatchdog.com

Individual inventors and corporate IP owners are used to dealing with accountants, lawyers and investment advisors – all professionals who are governed by state and/or federal professional regulations, and/or national association guidelines. Well, the ...

Share via E–mail | Twitter | Facebook

German Parliament Votes To Protect News Snippets From Republishing from www.ip-watch.org

Munich - A controversial update to German copyright law providing for an auxiliary protection for tiny extracts from press articles has been finally passed by the German Upper House (“Bundesrat”). Related Articles:

• Share via E–mail | Twitter | Facebook

Announcing Expert Speaker Panel for Pharma IPR 2013 from patentcircle.blogspot.com

The confirmed speakers for Pharma IPR 2013 taking place from 10-12 April at Holiday Inn Mumbai International Airport, Mumbai, India are as follows: Jeffrey Alan Hovden, Partner, Robins, Kaplan, Miller & Ciresi (USA) Sri K Sankaran ...

Share via E–mail | Twitter | Facebook

Discovery Process in Post-Grant Proceedings from www.patentlyo.com

by Dennis Crouch Abbott Labs v. Cordis Corp. (Fed. Cir. 2013) In 2009 Cordis sued Abbot for infringing two of its drug-eluting stent patents. US Patent Nos 6,746,773 and 7,591,844. Abbott ...

Share via E–mail | Twitter | Facebook

Federal Circuit Limits Discovery in Inter Partes Re-examination Proceedings from www.iplawalert.com

We reported last week on the discovery limitations under United States Patent and Trademark Office (“PTO”) guidelines as they pertain to inter partes review (“IPR”) proceedings. On Wednesday, in Abbott Labs. v. Cordis Corp., the ...

Share via E–mail | Twitter | Facebook

Conference Addresses Current Issues For Corporate IP Counsel from www.ip-watch.org

New York - A conference here this week aimed at corporate counsel for intellectual property addressed a range of issues of interest to that audience. Related Articles:

• World Congress Hosts 5th Annual Corporate IP Counsel Forum ...

Share via E–mail | Twitter | Facebook

ICANN Releases gTLD Initial Evaluation Results from www.ip-watch.org

The Internet Corporation for Assigned Names and Numbers (ICANN) today began posting the first generic top level domains (gTLDs) to pass Initial Evaluation of its new gTLD programme. Related Articles:

• ICANN To Reveal New Internet ...

Share via E–mail | Twitter | Facebook

PatCon 3: The Patent Conference from www.patentdocs.org

The University of Kansas School of Law, IIT Chicago-Kent College of Law, University of San Diego School of Law, and Boston College Law School will be holding the third annual Patent Conference -- PatCon 3 -- on ...

Share via E–mail | Twitter | Facebook

C5 Freedom to Operate Forum from www.patentdocs.org

C5 (UK) will be holding its 10th International Forum on Freedom to Operate on May 15-16, 2013 in Frankfurt, Germany. C5 faculty will offer presentations on the following topics: • A timeline of best practice at ...

Share via E–mail | Twitter | Facebook

Webinar on Impact of AIA on Claim Construction from www.patentdocs.org

Strafford will be offering a webinar/teleconference entitled "Advanced AIA Issues for Patent Claim Construction: Best Practices Absent Clear Court Guidance" on April 18, 2013 from 1:00 - 2:30 pm (EDT). Thomas L. Irving ...

Share via E–mail | Twitter | Facebook

C5 Pharma & Biotech Collaborations 2013 Conference from www.patentdocs.org

C5 (UK) will be holding its 2nd Forum on Pharma & Biotech Collaborations on May 14, 2013 in Frankfurt, Germany. C5 faculty will offer presentations on the following topics: • Identifying the current deal drivers and trends ...

Share via E–mail | Twitter | Facebook